Focuses on solid-state R&D, including polymorph, salt, and cocrystal screening, crystallization process development, and structural characterization using complementary techniques.
Mainland China / United StatesFull profile →
Pharmaceutical solid state · Companies
Matching companies load automatically. Browse 24 companies per page; expand filters to narrow the results.
Search & refine Filters update automatically
Disease tags identify mentions in recorded facts or pipeline text, not approved indications or a complete pipeline. Platform service providers may have no disease-specific tag.
24 matching companiesShowing 1–24 / 24
XtalGazer integrates prediction, automated experiments, SCXRD, and MicroED for solid-state research.
Mainland ChinaFull profile →
WuXi STA and WuXi Chemistry offer solid-form screening, polymorph quantification, structural analysis, and crystallization process development.
Mainland China / United StatesFull profile →
CMC materials science services include solid-state and physicochemical characterization and polymorph, salt, and cocrystal screening.
Mainland ChinaFull profile →
CDMO solid-state services can be contracted independently or integrated with API and drug product development, including salt and polymorph selection.
SwitzerlandFull profile →
A U.S. solid-state R&D and analytical CRO offering solid-form screening, structural characterization, and intellectual-property-related studies.
United StatesFull profile →
Pharmorphix solid-state and particle engineering services are now part of Veranova, spanning screening, crystallization development, and analytical support.
United StatesFull profile →
A European CDMO offering polymorph, salt, cocrystal, and amorphous-form screening and crystallization development.
BelgiumFull profile →
A contract provider focused on solid-state and particle characterization and analytical development for small-molecule drugs. Historical directory descriptions are not treated as evidence of a current comprehensive screening service.
SwitzerlandFull profile →
Almac Sciences' physical sciences services cover polymorph, salt, and cocrystal screening, crystallization development, and preformulation.
United Kingdom / United StatesFull profile →
A Japanese CMC contract research company combining solid-form selection with high-throughput nucleation, competitive slurry conversion, and structure determination.
JapanFull profile →
API development and manufacturing integrate crystallization engineering, salt selection, and polymorph screening.
Mainland ChinaFull profile →
Eurofins CDMO offers high-throughput polymorph, salt, and cocrystal screening and crystallization development.
LuxembourgFull profile →
Discovery and physical characterization services include pharmaceutical polymorph and salt screening.
United StatesFull profile →
API solid-form screening connects with crystallization process development to support physical stability, manufacturability, and drug development.
United StatesFull profile →
A Canadian CRO specializing in solid-state science and crystallization engineering, including polymorph, salt, and cocrystal screening and process optimization.
CanadaFull profile →
A Spanish solid-state and chemical R&D CRO offering screening, characterization, and scale-up of polymorphs, cocrystals, salts, and solvates.
SpainFull profile →
A solid-form screening and preclinical development CRO combining experimental screening with computational methods; MicroED is offered through its XtalPi partnership.
SpainFull profile →
Uses mSAS supercritical-fluid technology for crystal and particle engineering and enhanced polymorph screening.
United Kingdom / Mainland ChinaFull profile →
The CRO/CDMO solid-state team offers discovery, screening, crystallization development, and evaluation of new API solid forms.
Mainland ChinaFull profile →
An Ipca-owned small-molecule CDMO offering solid-state chemistry, salt and cocrystal screening, and chiral resolution support.
United KingdomFull profile →
CMC solid-state characterization and form-selection services; the website discloses salt screening and XRPD analysis.
GermanyFull profile →
Offers phase-appropriate comprehensive solid-form screening, single-crystal growth, structure determination, and crystallization process development.
United StatesFull profile →
A CRDMO offering salt and polymorph screening and solid-state characterization, with a disclosed dedicated solid-state laboratory.
IndiaFull profile →
Coverage expands from sourced records; this database does not claim all biopharma companies.